The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Liver metastases (LM) to predict for short overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts).
William Kevin Kelly
Research Funding - Sanofi
Susan Halabi
Research Funding - Sanofi
Michael Anthony Carducci
No relevant relationships to disclose
Daniel J. George
No relevant relationships to disclose
John Francis Mahoney
No relevant relationships to disclose
Walter Michael Stadler
Research Funding - Roche/Genentech
Michael J. Morris
Consultant or Advisory Role - Sanofi
Research Funding - Sanofi
Philip W. Kantoff
No relevant relationships to disclose
J. P. Monk
Research Funding - Sanofi
Eric Jay Small
No relevant relationships to disclose